Search Thermo Fisher Scientific
- Contact Us
- Quick Order
-
Don't have an account ? Create Account
Search Thermo Fisher Scientific
Confidence in COVID-19 testing results helps free us all to focus on the great things in life. PCR-based tests are designed to enable early virus detection, even in asymptomatic cases, and help deliver reliable answers.
The virus spread around the world in a few short months, and its variants continue to sweep the globe. The good news is that a robust testing program as part of an organization’s SARS-CoV-2 response can help mitigate the spread of the disease. Diagnostic testing can identify active coronavirus infection and inform proactive next steps, like quarantining, to protect the infected individual and close contacts.
As testing is critical to diagnose and contain the spread of the virus, there are multiple methodologies available to yield a coronavirus testing result. The two types of diagnostic tests discussed here are molecular lab-based PCR, which detects viral RNA, and antigen-based testing, which detects viral proteins (the antigen). PCR and antigen testing are described more fully below to help make strategic decisions regarding community testing, planning, and implementation.
There are different types of technologies used to test for SARS-CoV-2:
Accuracy takes into account sensitivity and specificity by measuring how the test can correctly identify if a sample is infected with SARS-CoV-2.
For the latest guidelines, please refer to:
The CDC:
https://www.cdc.gov/coronavirus/2019-ncov/lab/testing.html
https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antigen-tests-guidelines.html
The European CDC:
https://www.ecdc.europa.eu/en/publications-data/options-use-rapid-antigen-tests-covid-19-eueea-and-uk
The World Health Organization:
https://www.who.int/publications/i/item/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays
The decision to include PCR and antigen technologies in a testing program depends on the unique needs of the community. Importantly, community leaders should consider the organization's tolerance of an incorrect answer and the acceptability of that risk: what are the potential downstream effects of allowing an infected individual into the community because of a false negative result? Does convenience outweigh accuracy?
A clear understanding of the testing options is the first step in designing a testing program that will help keep the community safe. PCR tests, the gold standard for SARS-CoV-2 testing, provide high accuracy and therefore high confidence in the test results. Antigen tests are convenient when only a few results are needed, which may be advantageous in the point-of-care setting.